Who is sponsoring NCT03470597?

NCT03470597 is sponsored by Peking Union Medical College Hospital.

What drugs are being tested in NCT03470597?

Interventions in NCT03470597: dietary iodine restriction on subjects with iodine overload.

What condition does NCT03470597 study?

NCT03470597 studies Iodine Overload in Pregnancy.

Is NCT03470597 still recruiting?

NCT03470597 is currently status unknown. Last updated 20 March 2018.

Last reviewed 2018-03-20 · How we verify

NCT03470597

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry Study for Pregnant Women With Iodine Overload

Status unknown Last updated 20 March 2018

What this trial tests

trial testing dietary iodine restriction on subjects with iodine overload in Iodine Overload in Pregnancy in 195 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
1 March 2020

1 June 2020

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	195
Start date	1 April 2018
Primary completion	1 March 2020
Estimated completion	1 June 2020

Drugs / interventions tested

dietary iodine restriction on subjects with iodine overload

Conditions studied

Iodine Overload in Pregnancy — all drugs for Iodine Overload in Pregnancy →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 18 to 45, female only, with Iodine Overload in Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pre-gestational performance of hysterosalpingography (HSG) using an oil-soluble iodinated contrast medium has been demonstrated to be the main cause of excessive iodine exposure for pregnant women. However, its long-term health effects on the mothers and offsprings have not been adequately elucidated. A case registry study is designed to follow up all the pregnant women with pre-gestational history of ethiodized-oil HSG examination and try to keep track of maternal and fetal outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03470597 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 20 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03470597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing